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Abstract
Extraintestinal pathogenic Escherichia coli (ExPEC) strains, a major cause of bacteraemia, typically belong to phylogenetic group B2 and
express diverse accessory traits that contribute to virulence in mouse infection models. However, their high genomic diversity obscures
the relationship between virulence factors and severity of infection in patients. In this study, we analysed concomitantly the strain’s
expression of virulence in a mouse model, genomic determinants and the clinical severity of infection in 60 bacteraemic patients. We
show that bacterial virulence based on an animal model study and virulence factor determination is not correlated with pejorative out-
come of E. coli human blood infections.
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Introduction
The Escherichia coli species comprise commensal bacteria,
which belong to the normal gut microbiota of humans and
many animals, as well as highly virulent intestinal (InPEC) and
extra-intestinal (ExPEC) pathogenic variants. ExPEC form a
heterogeneous group of bacteria responsible for a large
spectrum of infectious diseases such as cystitis or pyelone-
phritis, meningitis, pneumonia, and bone or wound infections
[1]. ExPEC are also the leading cause of bacteraemic infec-
tions [1].
Phylogenetic analyses have established that E. coli can be
divided into four main groups (A, B1, B2 and D) and a more
recently described group E [2]. Classiﬁcation of pathogenic
E. coli is classically based on the presence or absence of spe-
ciﬁc DNA regions, referred to ‘pathogenicity islands’ (PAIs),
acquired by horizontal gene transfer [3]. These DNA regions
encode a large number of virulence factor (VFs) such as
adhesins, iron-acquisition systems, capsules and toxins [4]. It
is clearly established that these accessory genetic traits con-
tributed to intrinsic virulence of E. coli strains in a mouse
model of infection [5]. The B2 strains possess the highest
level of virulence factors [5].
Epidemiological studies have demonstrated that most clini-
cal strains of ExPEC belong to the phylogenetic group B2,
and to a lesser extent to the group D [1]. Also, several VFs
are known to be associated with the ExPEC phenotype [6].
However, ExPEC exhibit a considerable genomic diversity
[3] and none of the known VFs is constantly expressed in all
ExPEC strains [1].
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In the present study, we conducted a concomitant analysis
of (i) the intrinsic virulence of bacteraemic ExPEC strains
based on the presence or absence of speciﬁc DNA
sequences and virulence in mice and (ii) the severity of the
clinical infection caused by these strains to test whether a
correlation between these elements exists.
Materials and Methods
Patients, strains, macroarray assay
Sixty strains used for this study were selected among an
unbiased collection of 161 ExPEC strains corresponding to
all consecutive episodes of E. coli bacteraemia in two major
university hospitals in Paris [7,8]. This subset of 60 bacterae-
mic ExPEC was selected as being representative both of the
clinical characteristics of the sepsis and the bacterial charac-
teristics of the entire collection [7]. The considered clinical
characteristics were the portal of entry of the sepsis, the
severity of the disease [9], the immune status (immunodeﬁ-
ciencies included infection with human immunodeﬁciency
virus (HIV) with CD4+ count <200/mm3, administration of
immunosuppressive therapy (corticosteroid therapy >1 mg/
kg/day for >30 days, immunomodulating agents and anti-neo-
plastic chemotherapy) and neutropenia deﬁned as an
absolute granulocyte count of <500/lL) and the associated
co-morbidities (underlying solid tumour or haematological
malignancy, HIV-positive serology, diabetes mellitus (deﬁned
as requiring insulin or hypoglycaemiant therapy) and renal
failure (deﬁned as a creatinine clearance of <30 mL/min)).
The bacterial characteristics encompassed the phylogenetic
diversity of the strains based on PCR phylogrouping [10] and
MLST analysis [8]. These 60 bacteraemic ExPEC were also
characterized for the presence of nine well-documented VFs
(papC, papGIII, papGII, sfa, hlyC, cnf1, iut, iroN, fuyA) using a
multiplex PCR assay [11], and for the 40 most frequently
recovered O-antigens by an allele-speciﬁc polymerase chain
reaction as previously described [12,13]. To evaluate further
the accessory genomic content of each strain, a DNA mac-
roarray containing a large E. coli ﬂexible gene pool was used
[8]. Brieﬂy, DNA probes were selected using the genome
sequence of the O6:K15:H31 uropathogenic E. coli strain
536, the O6:K2:H1 uropathogenic E. coli strain CFT073, and
E. coli K-12 (MG1655). DNA sequences with more than 90%
of homology in the three genomes were excluded. In addi-
tion, speciﬁc sequences of the meningitis-associated strain
RS218, with less than 90% homology in the above three
strains, were included. This ﬂexible gene pool DNA macro-
array contains a total of 2324 probes that could be classiﬁed
in functional clusters according to their annotated function
(https://www.genoscope.cns.fr/agc/mage); that is, known viru-
lence factors (VF_sequences, n = 208), cell structure mem-
brane proteins (MB_sequences, n = 133), putative functional
enzymes (Met_sequences, n = 500), genomic regulator
(Transcriptional regulator_sequences, n = 104) and unknown
hypothetic protein (ORF_sequences, n = 1033). Genomic
DNA preparation and hybridizations were performed as pre-
viously described [8]. The macroarray data were analysed
using the ArrayVision software (Imaging Reseach, St Catha-
rines, Canada) for signal quantiﬁcation.
Murine infection
A mouse septicaemia model previously described [5] was
used to assess the intrinsic extra-intestinal virulence of all 60
human ExPEC E. coli. Between the isolation and the mouse
inoculation, these strains were not subcultured more than
three times. Brieﬂy, 10 outbred female Swiss mice (6–8
weeks old, 25–30 g) were challenged subcutaneously in the
abdomen with 109 cfu/mL of log-phase bacteria in 0.2 mL
Ringer solution [5]. Mortality was assessed over 7 days post-
challenge. It was previously established that when surviving
mice were euthanized at 7 days, the organs (blood, kidney,
liver and spleen) were sterile. Thus, a longer observation
was not contributive [5]. Each experimental series included a
positive control (urosepsis strain CFT073) and a negative
control (commensal derived strain K-12 MG1655). In this
model, lethality is a rather clear-cut parameter and strains
were usually classiﬁed either as non-killer (MNK, strains kill-
ing none or one mouse out of 10) or killer (MK, strains kill-
ing nine or ten mice out of 10) [14]. Strains that did not fall
into these two categories were considered as being interme-
diate killer (MIK). No signiﬁcant difference between the sur-
vival curves obtained with MK and MIK strains was
observed.
Animal experimentations were carried out according to
the authorization no. 6665 given by the Ministe`re de l’Agri-
culture, France.
Statistical methods
Comparisons were based on the chi-square test or Mann–
Whitney test for categorical variables and the Fisher exact
test when numbers were below ﬁve. All tests were two-
tailed and p <0.05 was considered signiﬁcant. Factorial analy-
sis of correspondence (FAC), a method suitable for studying
a very large amount of data, was used to describe associa-
tions among these data [15]. FAC is an eigenvector method
of ordination that uses a covariance matrix based on chi-
square distances. It describes the dispersion and shape of a
cloud of n objects (here, the E. coli strains) or p variables
(here, the studied variables) in a multidimensional space, by
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replacing the original dataset with a new set of orthogonal
linear coordinates in a space of signiﬁcantly lower dimension.
The explained variances of the elements of the dataset (the
strains and the variables) are in decreasing order of magni-
tude with respect to these new coordinates. The variables
used for FAC are categories. The computation determines a
plane deﬁned by the ﬁrst two principal axes of the analysis;
the ﬁrst axis, F1, accounts for most of the variance, and the
second axis, F2, orthogonal to F1, accounts for the largest
part of the variance that is not accounted for by F1.
Several FACs were conducted with SPAD.N software
(Cisia, Saint Mande´, France) from ﬁve two-way tables. These
tables had 60 rows, one for each E. coli strain and 230, 140,
270, 53 and 268 columns corresponding to the same numbers
of variables included in the ﬁve tables considering the VF_,
MB_, Met_, ORF_ and Transcriptional regulator_ sequences,
respectively, studied in the macroarray plus the mouse lethality
data, the phylogenetic groups of the strains and the character-
istics of the patients. Within each table, for each column, each
strain was coded as a binary code: present = 1, absent = 0.
Results
A strong association between the phylogenetic group, the
virulence factor content of each strain and virulence in mice
is observed
Of the 60 selected strains, 27 (45%) belonged to the B2 group
whereas 15 (25%), 11 (18%) and 7 (12%) strains belonged to
the D, A and B1 groups, respectively. In agreement with previ-
ous results, strains of the B2 group appeared as being the most
virulent strains in mice (44% of B2 group strains are killer
strains), followed by the D group strains (33% killer strains). At
the opposite, A and B1 group strains were non-virulent in mice
(27% and 0% killer strains, respectively). It is well documented
that pathogenic E. coli strains exhibit considerable genome
diversity [3,16]. Here, we investigated the genome diversity of
the 60 bacteraemic ExPEC strains by macroarray analysis, as
described in the materials and methods section. We searched
for a correlation between the presence of VF-related
sequences and the high virulence expressed in mice. To this
end, we compared the proﬁles of genes between killer (MK)
and non-killer (MNK) strains. Thirty-eight per cent of
VF-related genes (80 of 208 sequences, described in reference
[8]) were signiﬁcantly more prevalent in MK than in MNK (p
comprised between <0.01 and 0.05). A large number of the
genes that were over-represented in MK strains encoded for
iron capture systems (n = 38; 76% in MK vs. 55% in MNK,
p 0.029) and capsule determinants (n = 27; 44% vs. 26%,
p 0.003). Finally, we determined the O-types of the 60 studied
strains by an allele-speciﬁc PCR assay [12,13]. Using this
approach, 48 strains (80%) were typable, with a clear association
between speciﬁc O-types and phylogroups (Table S1), as previ-
ously reported [13,17–19]. Altogether, these results show a
strong association between the phylogenetic group, the O-type,
the virulence factor content of each strain and virulence in mice.
In order to conﬁrm this association, we conducted an
FAC on the VF genes, the phylogenetic groups and the
mouse lethality data. The projections of the variables on the
plane F1/F2, which accounted for 39.9% of the total variance,
distinguished the B2 group, most virulence genes (including
the genes identiﬁed by PCR: cnf, sfa, kps, iroN, papC and hly)
on the negative values of the ﬁrst factor F1 from the A and
B1 groups and a very few VF on the positive values of this
factor. The phylogenetic group D was projected on to the
negative values of the second factor F2 (Fig. 1). The variables
MK and MIK were projected on to lower negative values of
F1 than the B2 group, whereas the variable MNK was pro-
jected on to lower positive values of F1 than the A and B1
groups. The four FAC conducted on the MB_, Met_, Tran-
scriptional regulator_ and the ORF_sequences retrieved simi-
lar results: a clear distinction of the four phylogenetic
groups, indicating a strong clonal structure of the species,
and a correlation between the B2 group and the mouse
lethality (data not shown). Importantly, these results show
that genomic diversity in bacteraemic ExPEC was determined
by VF_sequences but also by other classes of genes such as
metabolic-related sequences (Met_sequences).
More severe issue of sepsis in human E. coli infection is not
related to virulence in the mouse model
To examine whether an association might exist between the
severity of the sepsis in humans and the virulence of these
strains in mice, an FAC was conducted on the phylogenetic
groups, the mouse lethality data and the clinical data. The
projections of the variables on the plane F1/F3, which
accounted for 30.27% of the total variance, distinguished a
ﬁrst group of variables (B2 group, MK variable, urinary tract
origin of the sepsis, immunocompetent character of the
patients, and presence of co-morbidity factor) by negative
values of the factor F3 from a second group (phylogenetic
groups A and B1, MNK variable and digestive origin of the
sepsis) by the positive values of the two factors (Fig. 2). The
severity of the bacteraemia and the death of the patients
were orthogonally projected (i.e. independently) from the
other variables, according to the negative values of the ﬁrst
factor F1. Similarly, the severity of the sepsis in humans was
not correlated with the O-types of the strains (data not
shown). Altogether, these data strongly suggest that there is
no correlation between the virulence of ExPEC in mice and
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the severity of the sepsis. More severe issue of sepsis in
human E. coli infection is not related to virulence in the
mouse model.
Discussion
In this study, we analysed concomitantly the intrinsic viru-
lence of ExPEC strains assessed by the bacterial genomic
content and the lethality in a mouse model [5,14], and the
severity of bacteraemia including diverse portal of entry in
patients. We showed that B2 strains are more likely to be
virulent in mice and that VF sequences were most highly
represented in this B2 phylogenetic group of E. coli. Similarly,
several rodent models of bacteraemia using various routes of
inoculation [5,14,20,21] of urinary tract infection [22] and of
meningitis [20], as well as non-rodent models, zebra ﬁsh
[23], locust [24], Caenorhabditis elegans [25] and Dyctostelium
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FIG. 1. Projections of the 217 VFs studied by the macroarray and PCR, the mouse lethality data and the phylogenetic groups of the 60 E. coli
strains on the plane F1/F2 computed from the factorial analysis of correspondence. The abbreviations are as follows. MK, MIK, MNK: mouse
killer, mouse intermediate killer, mouse non-killer. A, B1, B2, D: phylogenetic groups A, B1, B2 and D. Particular VFs are indicated: cnf, sfa, kps,
iroN, hly and papC ( ) corresponded to the projections of the variables.
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FIG. 2. Projections of the bacterial and clinical variables characterized in the 60 E. coli strains on the plane F1/F3 computed from a factorial anal-
ysis of correspondence considering the mouse lethality data and the phylogenetic groups of the strains, the origin, the evolution of the bactera-
emia and the characteristics of the patients. The abbreviations are as follows. MK, MIK, MNK: mouse killer, mouse intermediate killer, mouse
non-killer. A, B1, B2 and D: phylogenetic groups A, B1, B2 and D. UT, DT, IMC, CM and SS 3–4: urinary tract or digestive tract portal of entry,
immunocompromised, co-morbidity and septic score 3–4 [9].
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discoidum [26], have found a correlation between the B2 phy-
logenetic group, the presence of VF genes and the experi-
mental pathogenicity. However, these works were not
focused on the relationships between the intrinsic virulence
and the clinical severity of the infection. Epidemiological
studies showed that B2 strains were over-represented in
clinical pathogenic strains. Also, speciﬁc accessory traits
admitted as virulence factors were described as highly preva-
lent and responsible for a speciﬁc pathogenic proﬁle of
ExPEC strains [1,27]. Nevertheless, it is well documented
that pathogenic strains of E. coli exhibit considerable genomic
diversity [3,16].
No correlation has been evidenced between the presence
of a set of VFs and the outcome of an infection in the host
[3], or between the severity of sepsis and phylogenetic
groups of strains [8,28]. In a large prospective study including
1051 consecutive E. coli bacteraemia, severity of clinical out-
come was more strongly associated with speciﬁc characteris-
tics of the patient, especially immune status, and with the
portal of entry, than with bacterial determinants [29]. In
another study, Johnson et al. [27] have shown that associa-
tions between bacterial factors of E. coli bacteraemic isolates
and host characteristics were highly variable, depending on
the primary source of bacteraemia.
In this study, we show that the ability to be septicaemic in
humans does not correlate with virulence in mice. Numer-
ous strains isolated from blood cultures are not virulent in
the mouse model. No link was observed between the sever-
ity of sepsis and the killer status of strains in mice. Addition-
ally, the deﬁnition of bacterial virulence based on animal
model studies and VF determination was not correlated with
more severe evolution of E. coli human blood infections. The
evolution of human blood infection is dependent on many,
often heterogeneous, host factors. These include immune
status, which may explain the lack of correlation with obser-
vations in animal models. Finally, classical genes so-called ‘vir-
ulence factors’ that are described from experimental data
obtained in mice may not be the determinants of the
ExPEC’s intrinsic virulence explaining the severity of infection
in humans.
With subcutaneous bacterial injection, the mouse model
tests essentially the ability of a strain to be able to survive in
the extracellular ﬂuid. Indeed, the usual VFs associated with
the ExPEC phenotypes are those that allow the bacteria to
resist phagocytosis by polymorphonuclear neutrophils, killing
by complement, and promote bacterial ability to chelate the
ferric iron from iron-containing molecules. One point that
the mouse model does not address is the ability of the bac-
teria to disseminate from the portal of entry. The above data
showing no correlation between the severity of the sepsis
on the one hand and the mortality in mice, or the expres-
sion of usual virulence factors, on the other hand, may sug-
gest that survival in the extracellular ﬂuids is not as
important as initially believed from the data obtained in
mouse models of septicaemia [30].
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